KLOW 80mg

Four Compounds. Four Pathways. Zero Overlap.

KLOW brings together BPC-157, TB-500, GHK-Cu, and KPV in a single vial — four peptides with non-overlapping mechanisms studied across tissue repair, gene expression, and inflammatory research.

Why Researchers Study It

• BPC-157 — vascular infrastructure and growth factor signaling
• TB-500 — actin regulation and cell migration
• GHK-Cu — gene expression modulation (3,150+ genes)
• KPV — NF-κB inhibition, direct anti-inflammatory cascade

What Makes It Different

Each compound targets a different phase of the repair process. Structural + cellular + genetic + anti-inflammatory. No redundancy. Full-spectrum recovery research in one blend.

Analytical Documentation

• Purity: Batch-specific Certificate of Analysis (COA) included
• Method: HPLC and/or LC-MS verification
• Storage: Lyophilized — store cool, dry, protected from light